跳至主要内容
临床试验/NCT03230682
NCT03230682Unknown不适用

Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder

Huashan Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年7月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
Early improvement

研究概览

简要总结

Early improvemrnt, decreased 20% in the 17 items of Hamilton Depression Rating Scale (HAMD-17) at the second week of the treatment of major depression disorder (MDD), can arguably predict the remission at the 12th week. Our observation study including 80 MDD patients will access resting-state function MRI to finding factors which infuencing early improvemrnt, respone and remission of antidepressants.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 55 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • right-handed; HAMD-17 more than 17; diagnosed with MDD by the Structured Clinical Interview for DSM-IV

排除标准

  • patients diagnosed with other condition in DSM-IV Axis I; pregnency; Thyroid disease; Heart Disease

研究组 & 干预措施

major depressive disorder

干预措施: antidepressant (Drug)

结局指标

主要结局

Early improvement

时间窗: the second week of treatment

obtain 20% decrease of HAMD-17

次要结局

  • Response(the 12th week of treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jianhui Fu

Department of Neurology, Huashan Hospital

Huashan Hospital

研究点 (1)

Loading locations...

相似试验